Related Experiment Videos
Neuroimmune activation in chronic heart failure
Giorgio Fiore1, Patrizia Suppress, Vincenzo Triggiani
1Internal Medicine, Allergology and Clinical Immunology, Department of Emergency and Organ Transplatation, University of Bari, Bari, Italy. giorgio.fiore@uniba.it
Endocrine, Metabolic & Immune Disorders Drug Targets
|February 2, 2013
Summary
Cardiac hypertrophy can lead to heart failure due to neuroimmune imbalances. This review explores neuroimmune pathways and current therapeutic strategies for chronic heart failure (CHF).
Area of Science:
- Cardiology
- Neuroimmunology
- Pharmacology
Background:
- Cardiac hypertrophy and remodeling are critical conditions predisposing to heart failure and organ dysfunction.
- These conditions result from neuroendocrine, autonomic, and immune system imbalances.
- Sympathetic over-excitation and parasympathetic withdrawal contribute to immune activation in chronic heart failure (CHF), influenced by central nervous system inflammation.
Purpose of the Study:
- To review the neuroimmune-mediated pathways implicated in chronic heart failure (CHF).
- To shed light on current therapeutic strategies for CHF.
- To highlight the need for molecularly targeted drugs in CHF management.
Main Methods:
- Literature review focusing on neuroimmune pathways in CHF.
- Analysis of current therapeutic approaches for chronic heart failure.
- Exploration of molecularly targeted drug development for CHF.
Main Results:
- The review identifies significant roles for neuroendocrine, autonomic, and immune dysregulation in CHF.
- Central nervous system inflammation and immune activation are key components.
- Current CHF management still requires novel, targeted therapies.
Conclusions:
- Neuroimmune pathways are central to the pathophysiology of chronic heart failure.
- Targeted therapies addressing these neuroimmune mechanisms are crucial for effective CHF management.
- Further research into molecularly targeted drugs is warranted for improved clinical outcomes in CHF.
Related Concept Videos
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...